Stiripentol 250 mg, 500 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules / Oral Suspension
Available Strengths: 250 mg, 500 mg
Reference Brands: Diacomit (UES/EU)
Category: Neurology
Stiripentol is a Neurology product available as Capsules / Oral Suspension in strengths 250 mg, 500 mg. It corresponds to the reference brand Diacomit (UES/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Stiripentol is an anticonvulsant medication used for the treatment of Dravet syndrome, a rare and severe genetic epilepsy that begins in infancy and is characterized by refractory seizures. Marketed under the brand name Diacomit, stiripentol is approved in the European Union as an adjunctive therapy in combination with clobazam and valproate for patients whose generalized tonic-clonic seizures are not adequately controlled with standard treatment.
Stiripentol exerts its antiepileptic effects by enhancing gamma-aminobutyric acid (GABA)–mediated neurotransmission in the central nervous system, helping to reduce neuronal excitability. In addition, it inhibits specific cytochrome P450 enzymes, increasing the plasma concentrations and therapeutic effectiveness of co-administered antiepileptic drugs such as clobazam. This synergistic action contributes to improved seizure control in patients with severe myoclonic epilepsy in infancy.
The medication is administered orally in capsule form or as a powder for oral suspension and is prescribed under specialist supervision due to its potential for drug–drug interactions. Stiripentol plays a critical role in the long-term management of Dravet syndrome, helping reduce seizure frequency and severity in affected patients.
Stiripentol — third party manufacturing & bulk supply
Stiripentol 250 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Stiripentol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Stiripentol →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Stiripentol is used as an adjunctive treatment for seizures associated with Dravet syndrome, a rare and severe form of childhood epilepsy. It is prescribed in combination with clobazam and valproate when seizures are not adequately controlled by standard therapy.
Stiripentol is a synthetic antiepileptic compound formulated for oral administration in capsule form or as a powder for oral suspension.
The trade name of stiripentol is Diacomit.
Stiripentol under the brand name Diacomit is manufactured and marketed by Biocodex.
The generic name is stiripentol.
The brand name is Diacomit.
Stiripentol is manufactured in facilities approved by regulatory authorities, primarily in Europe, in compliance with international pharmaceutical manufacturing standards.
Related Products
Valproic Acid
Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
View Details
Quick Response Guaranteed | Verified Suppliers
